Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
| Actual shortage: | 212 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 297 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-16 | 2023-10-06 | 195078 |
| TEVA-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-20 | 2023-07-05 | 195827 |
| TEVA-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-03 | 2024-11-25 | 209148 |
| TEVA-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-10-30 | 2021-04-01 | 127616 |
| TEVA-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-11-06 | 2021-01-28 | 128025 |
| TEVA-TECNAL | 50MG 40MG 330MG | TABLET | Resolved | 2020-07-23 | 2020-09-24 | 120896 |
| TEVA-TECNAL | 330MG 40MG 50MG | TABLET | Resolved | 2022-04-21 | 2024-01-19 | 159189 |
| TEVA-TECNAL | 330MG 40MG 50MG | CAPSULE | Resolved | 2022-07-25 | 2022-10-18 | 165459 |
| TEVA-TECNAL | 330MG 40MG 50MG | CAPSULE | Resolved | 2022-02-10 | 2022-07-01 | 154714 |
| TEVA-TECNAL | 330MG 50MG 40MG | TABLET | Resolved | 2019-06-13 | 2019-07-15 | 86620 |
| TEVA-TECNAL | 330MG 40MG 50MG | TABLET | Resolved | 2023-06-20 | 2023-07-06 | 195850 |
| TEVA-TECNAL | 330MG 40MG 50MG | CAPSULE | Resolved | 2024-04-05 | 2024-06-13 | 224448 |
| TEVA-TECNAL | 330MG 40MG 50MG | CAPSULE | Actual shortage | 2024-09-05 | 2025-03-27 | 236799 |
| TEVA-TECNAL | 330MG 50MG 40MG | CAPSULE | Resolved | 2019-08-29 | 2020-07-10 | 92657 |
| TEVA-TECNAL C 1/2 | 330MG 50MG 30MG 40MG | CAPSULE | Resolved | 2019-10-31 | 2020-02-07 | 97608 |
| TEVA-TECNAL C 1/2 | 30MG 330MG 40MG 50MG | CAPSULE | Resolved | 2021-12-17 | 2022-03-24 | 151439 |
| TEVA-TECNAL C 1/2 | 330MG 50MG 30MG 40MG | CAPSULE | Resolved | 2020-03-06 | 2020-03-26 | 107973 |
| TEVA-TECNAL C 1/2 | 50MG 40MG 330MG 30MG | CAPSULE | Resolved | 2021-03-25 | 2021-04-15 | 136310 |
| TEVA-TECNAL C 1/2 | 30MG 330MG 40MG 50MG | CAPSULE | Resolved | 2024-03-18 | 2024-05-09 | 222560 |
| TEVA-TECNAL C 1/4 | 330MG 50MG 15MG 40MG | CAPSULE | Resolved | 2020-03-12 | 2020-07-09 | 108620 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 40MG | POWDER FOR SOLUTION | Discontinued | 2021-09-23 | 2021-09-23 | 146061 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-04-11 | 2019-04-11 | 81321 |
| NOVAMOXIN | 500MG | CAPSULE | Discontinued | 2017-06-27 | 2017-06-27 | 14046 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81316 |
| NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
| NOVAMOXIN | 25MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81393 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
| NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
| NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
| NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 |